The funds are expected to go toward bringing in new employees and accelerating the development of a new cardiac imaging offering. 

According to Ajax Health CEO and industry veteran Duke Rohlen, the new company will be focused on offerings that "prioritize precision, simplicity and efficiency."

The alleged scheme involved a series of diagnostic procedures that, according to the U.S. government, were not medically necessary. 

Medtronic confirmed its decision in a statement, but did not provide any specific details. The deal was originally announced in May.

The policies cover a wide range of interventional therapies, including Shockwave Medical's IVL technology and intravascular ultrasound. 

How do changes in ownership impact patient care? That was one of the many topics explored in a new survey of U.S. physicians.

Roche, one of the world’s largest pharmaceutical companies, will gain both oral and injectable assets as a result of this acquisition.

The deal could also include additional clinical and regulatory milestone payments in the years ahead.